Ania Jastreboff, MD, PhD
Disclosures: Advisory Board / Consultant-Novo Nordisk|Advisory Board / Consultant-Eli Lilly and Company|Consultant-Boehringer Ingelheim|Advisory Board / Consultant, stock options-Intellihealth|Consultant-Scholar Rock|Advisory Board / Consultant-Pfizer, Inc.|Research Grant Support-American Diabetes Association|Multi-center clinical trial-Novo Nordisk|Multi-center clinical trial-Eli Lilly and Company|Research Grant-NIH/NIDDK|Spouse - Consultant-Agios|Spouse - Advisory committee, stock options-Pangolin Therapeutics|Spouse - scientific co-founder, stock options-Elucidata|Spouse - consultant-Agios - 09/27/2021

 

Ania M. Jastreboff, MD, PhD is an Associate Professor of Internal Medicine & Pediatrics (Endocrinology & Pediatric Endocrinology) at Yale University School of Medicine, Director of Weight Management and Obesity Prevention at the Yale Stress Center, and co-Director of the Yale Center for Weight Management.

 

After completing a Med/Peds Residency, Dr. Jastreboff completed a dual fellowship in both Adult Endocrinology and Pediatric Endocrinology during which she also completed a PhD in the neurobiology of obesity, becoming board certified in Obesity Medicine, Adult Endocrinology, and Pediatric Endocrinology.

 

Dr. Jastreboff is a clinically active physician-scientist who specializes in sophisticated use of anti-obesity medication combinations. She is nationally recognized for helping to develop the 2016 AACE/ACE Clinical Practice Guidelines for The Care of Patients with Obesity, serving on the Board of Director for the American Board of Obesity Medicine (ABOM), Chairing the Obesity Society (TOS) Clinical Care Committee, and most recently, serving as co-Chair with Dr. Aaron Kelly for the TOS Pediatric Obesity Treatment Task Force.

 

Dr. Jastreboff’s conducts cutting-edge clinical translational obesity research which is funded by the NIH/NIDDK (R01s), American Diabetes Association (ADA), and industry and includes large, multi-center clinical outcomes trials using anti-obesity medication as well as studies examining the neurobiology underlying obesity and mechanisms of anti-obesity medications.

 

Dr. Jastreboff enthusiastically teaches the next generation of Obesity Medicine physicians by serving as teaching faculty annually at the Harvard Blackburn Treating Obesity course, the Columbia/Cornell Obesity course, selected international courses, and, of course, she is excited to teach again at the Advanced Therapeutics for Pediatric Obesity (ATPO) course!